Founder Profile
John W. Daniels
Last reviewed: 2026 · By Swet Parvadiya
Background
John W. Daniels founded the original Daniels Linseed Co. in 1902 with a specific mission to build a highly efficient, mechanized processing facility that could capture the massive value added by converting raw linseed into industrial oil and meal, a product that would eventually become the foundational asset of the future ADM empire. His defining founding philosophy was that physical processing scale and mechanical efficiency would build a business that could transcend the extreme volatility of raw agricultural commodity prices, a vision that laid the groundwork for the modern global agricultural processing industry.
Founding Story
John W. Daniels is the foundational founder of the ADM enterprise, having established the original Daniels Linseed Co. in Minneapolis, Minnesota, in 1902. Daniels brought a ruthless focus on mechanical efficiency and processing scale to the traditionally fragmented linseed crushing industry. Before founding the company, he recognized that the traditional agricultural market was dominated by low-value raw commodity trading, and envisioned a completely different way to capture value: a highly mechanized facility that could extract maximum yield from raw seeds and convert them into high-value industrial ingredients. Daniels's deep understanding of mechanical engineering, combined with his vision for industrial processing, allowed him to build the Daniels Linseed brand into a dominant regional player, which became a critical profit center for the company and a primary driver of its eventual merger with Archer Linseed. During the company's early expansion, Daniels maintained strict operational control, ensuring that every bushel of seed processed adhered to the high-yield standards that defined the brand's DNA. His leadership during the formative years established the corporate culture of processing obsession and long-term asset scale that continues to drive ADM's strategic decisions today, including the massive investments in biological processing and derivative diversification.